MedTrace Logo

The Gynecological Cancer Associated Thrombosis (GynCAT) Study

NCT06284343 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2024-09-19

No results posted yet for this study

Summary

GynCAT is a prospective cohort study that will be conducted on female patients with gynecologic malignancies scheduled for systemic antineoplastic treatment, aiming at development and validation of a Risk Assessment Model (RAM) for Venous Thromboembolism (VTE) in this specific population.

Conditions

Interventions

DRUG

Anticoagulant

Prescription of pharmacological thromboprophylaxis according to current clinical practice and international guidelines recommendation

Sponsors & Collaborators

  • Fondazione Umberto Veronesi

    collaborator OTHER

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Roberto Pola, PhD; MD · Agostino Gemelli University Polyclinic Foundation IRCCS

  • Paolo Santini, MD · Agostino Gemelli University Polyclinic Foundation IRCCS

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-15
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06284343 on ClinicalTrials.gov